Source link : https://newshealth.biz/health-news/ruxolitinib-cream-approved-for-children-aged-2-11-with-ad/
Ruxolitinib is the first topical JAK inhibitor approved in the US for pediatric AD. Medscape Medical News Source link : https://www.medscape.com/viewarticle/ruxolitinib-cream-approved-children-aged-2-11-atopic-2025a1000ow3?src=rss Author : Publish date : 2025-09-19 05:22:00 Copyright for syndicated content belongs to the linked Source.
The post Ruxolitinib Cream Approved for Children Aged 2-11 With AD first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-19 05:22:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8